Anyone else hear this? SGI-1776 could be the first ever kinase inhibitor to hit clinical trials... Dr. M said something along the lines of "Some of the larger pharmaceutical companies have been very interested in this drug"...
Not a direct quote, but the jist of it sounds like there's been outside interest, a potential partnership?
I missed the first 10 minutes of the call, anything else go on? I bounce in with them talking about Eisai S110 first-right to offer.
So far, they're sounding pretty confident. Definitely uplifting!
i have been in and out of supg over the years, got back in yesterday due to the news release on sg1776, then did some research and found the following: cash $1.5/share book $1.6 i know that i have stated the obvious, but sometimes owners loose site of existing fundamentals.